FYERS
Home
/
Stocks
/
Profit Loss
/
Sudarshan Pharma Industries Profit & Loss

Sudarshan Pharma Industries Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
₹174 Cr₹221 Cr₹168 Cr₹169 Cr₹145 Cr₹162 Cr₹116 Cr₹129 Cr₹99 Cr
₹1 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹84 L₹51 L₹32 L₹98 L
₹176 Cr₹225 Cr₹170 Cr₹171 Cr₹146 Cr₹162 Cr₹116 Cr₹129 Cr₹100 Cr
₹160 Cr₹202 Cr₹158 Cr₹161 Cr₹135 Cr₹146 Cr₹108 Cr₹116 Cr₹98 Cr
₹17 Cr₹24 Cr₹12 Cr₹11 Cr₹12 Cr₹17 Cr₹8 Cr₹13 Cr₹3 Cr
₹8 Cr₹8 Cr₹6 Cr₹6 Cr₹6 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹8 Cr₹16 Cr₹5 Cr₹4 Cr₹5 Cr₹10 Cr₹4 Cr₹8 Cr-₹2 Cr
₹6 Cr₹11 Cr₹4 Cr₹4 Cr₹4 Cr₹7 Cr₹3 Cr₹6 Cr-₹1 Cr

Share Price Live Stats

Open (₹)40.00
Volume (₹)1.40 L
High (₹)40.00
Upper Circuit41.97
Low (₹)38.05
Lower Circuit37.99
Prev Close39.98
52W High (₹)42.79
Price38.30
52W Low (₹)18.50

Share Market Cap & Key Ratios Overview

M.Cap (₹)1017.37 Cr
Div. Yield (%)0.00
PE Ratio40.50
Debt to Equity1.34
Price to Book5.76
Book Value5.30
EPS (TTM)0.99
Face Value1.00
ROE (%)13.33

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
SUDARSHAN-MNSE
LTP
1W Low
1W High
Market cap (₹)
1848.8+13.3 (0.72%)
1835.50
1890.40
4,47,476Cr
9626.9+259.9 (2.77%)
9305.95
9739.85
2,54,764Cr
4927.65+123.4 (2.57%)
4864.80
5010
1,89,423Cr
1186.3+33.3 (2.89%)
1152
1191
1,16,658Cr
1400.9+29.45 (2.15%)
1364
1418.70
1,11,484Cr
2026.25+71 (3.63%)
1964.50
2054.55
1,09,943Cr
2480.9+162.9 (7.03%)
2302.30
2503.20
1,01,712Cr
1201.8+30.7 (2.62%)
1186.20
1221.60
1,01,005Cr
1714.1-20.9 (-1.20%)
1690
1739.60
99,253Cr
2094.7-50 (-2.33%)
2084.50
2129.85
96,031Cr
38.3-1.37 (-3.45%)
38.05
40.69
1,017Cr

Key Highlights of Sudarshan Pharma Industries Ltd’s P&L

In 2025-03-31, Sudarshan Pharma Industries Ltd reported total revenue of ₹507.57Cr, compared with ₹466.15Cr in 2024-03-31, reflecting Sudarshan Pharma Industries Ltd turnover.

Depreciation was ₹2.22Cr and finance costs were ₹15.77Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹21.63Cr in 2025-03-31 as compared to ₹15.23Cr in 2024-03-31.

Net Profit (PAT) was ₹15.96Cr in 2025-03-31 compared with ₹11.46Cr in 2024-03-31.

Earnings per share (EPS) were ₹0.66 in 2025-03-31, compared with ₹4.76 in 2024-03-31.